Barr Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | 68.0 | 101.0 | 125.9 | 107.8 | 17.2 |
| Net Investing Cash Flow | (19.0) | 187.0 | (28.1) | 202.8 | 54.1 |
| Net Financing Cash Flow | (18.0) | (56.0) | (67.3) | (309.8) | (57.5) |
| Net Change in Cash | 29.0 | 238.0 | 34.2 | 8.4 | 9.3 |
| Depreciation & Amortization | 88.0 | 78.0 | 76.4 | 77.9 | 71.2 |
| Capital Expenditures | (33.0) | (29.0) | (43.1) | (30.4) | (26.7) |
| Cash Dividends Paid | 0.0 | (6.0) | -- | -- | -- |
This data is provided as per license from EDGAR Online
